\relax 
\providecommand\hyper@newdestlabel[2]{}
\providecommand\HyperFirstAtBeginDocument{\AtBeginDocument}
\HyperFirstAtBeginDocument{\ifx\hyper@anchor\@undefined
\global\let\oldcontentsline\contentsline
\gdef\contentsline#1#2#3#4{\oldcontentsline{#1}{#2}{#3}}
\global\let\oldnewlabel\newlabel
\gdef\newlabel#1#2{\newlabelxx{#1}#2}
\gdef\newlabelxx#1#2#3#4#5#6{\oldnewlabel{#1}{{#2}{#3}}}
\AtEndDocument{\ifx\hyper@anchor\@undefined
\let\contentsline\oldcontentsline
\let\newlabel\oldnewlabel
\fi}
\fi}
\global\let\hyper@last\relax 
\gdef\HyperFirstAtBeginDocument#1{#1}
\providecommand\HyField@AuxAddToFields[1]{}
\providecommand\HyField@AuxAddToCoFields[2]{}
\providecommand \oddpage@label [2]{}
\babel@aux{english}{}
\@writefile{toc}{\contentsline {chapter}{\numberline {1}Transcription}{3}{chapter.1}\protected@file@percent }
\@writefile{lof}{\addvspace {10\p@ }}
\@writefile{lot}{\addvspace {10\p@ }}
\@writefile{loa}{\addvspace {10\p@ }}
\@writefile{toc}{\contentsline {section}{\numberline {1.1}Recap on transcription}{3}{section.1.1}\protected@file@percent }
\@writefile{toc}{\contentsline {section}{\numberline {1.2}2- Transcriptional Control in Cancer}{3}{section.1.2}\protected@file@percent }
\newlabel{transcriptional-control-in-cancer}{{1.2}{3}{2- Transcriptional Control in Cancer}{section.1.2}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {1.2.1}Transcription initiation}{3}{subsection.1.2.1}\protected@file@percent }
\newlabel{transcription-initiation}{{1.2.1}{3}{Transcription initiation}{subsection.1.2.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.1}{\ignorespaces Screenshot 2022-09-16 at 12.11.22.png\relax }}{3}{figure.caption.2}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {1.2}{\ignorespaces Screenshot 2022-09-16 at 15.53.19.png\relax }}{4}{figure.caption.3}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {1.2.2}Chromatin remodeling}{5}{subsection.1.2.2}\protected@file@percent }
\newlabel{chromatin-remodeling}{{1.2.2}{5}{Chromatin remodeling}{subsection.1.2.2}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {1.2.2.1}Techniques to study chromatin remodelling}{5}{subsubsection.1.2.2.1}\protected@file@percent }
\newlabel{techniques-to-study-chromatin-remodelling}{{1.2.2.1}{5}{Techniques to study chromatin remodelling}{subsubsection.1.2.2.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.3}{\ignorespaces Screenshot 2022-09-16 at 16.26.04.png\relax }}{6}{figure.caption.4}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {1.2.3}Nucleosome organization}{6}{subsection.1.2.3}\protected@file@percent }
\newlabel{nucleosome-organization}{{1.2.3}{6}{Nucleosome organization}{subsection.1.2.3}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {1.2.3.1}Nucleosome remodelling}{6}{subsubsection.1.2.3.1}\protected@file@percent }
\newlabel{nucleosome-remodelling}{{1.2.3.1}{6}{Nucleosome remodelling}{subsubsection.1.2.3.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.4}{\ignorespaces Screenshot 2022-09-16 at 16.30.29.png\relax }}{7}{figure.caption.5}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {1.5}{\ignorespaces Screenshot 2022-09-23 at 15.22.44.png\relax }}{7}{figure.caption.6}\protected@file@percent }
\@writefile{toc}{\contentsline {section}{\numberline {1.3}3 (1)}{7}{section.1.3}\protected@file@percent }
\newlabel{section}{{1.3}{7}{3 (1)}{section.1.3}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.6}{\ignorespaces Screenshot 2022-09-22 at 21.36.39.png\relax }}{8}{figure.caption.7}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {1.3.1}Main nucleosome modifications in promoters:}{8}{subsection.1.3.1}\protected@file@percent }
\newlabel{main-nucleosome-modifications-in-promoters}{{1.3.1}{8}{Main nucleosome modifications in promoters:}{subsection.1.3.1}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {1.3.1.1}RT-qPCR based detection of 5' RNA transcripts of inactive genes}{8}{subsubsection.1.3.1.1}\protected@file@percent }
\newlabel{rt-qpcr-based-detection-of-5-rna-transcripts-of-inactive-genes}{{1.3.1.1}{8}{RT-qPCR based detection of 5' RNA transcripts of inactive genes}{subsubsection.1.3.1.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.7}{\ignorespaces Screenshot 2022-09-22 at 21.49.05.png\relax }}{9}{figure.caption.8}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {1.3.1.2}Global run-on sequencing (GRO-seq)}{9}{subsubsection.1.3.1.2}\protected@file@percent }
\newlabel{global-run-on-sequencing-gro-seq}{{1.3.1.2}{9}{Global run-on sequencing (GRO-seq)}{subsubsection.1.3.1.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.8}{\ignorespaces Screenshot 2022-09-22 at 21.58.03.png\relax }}{10}{figure.caption.9}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {1.9}{\ignorespaces Differential phosphorylation of RNA Pol II CTD during transcription.\relax }}{10}{figure.caption.10}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {1.10}{\ignorespaces Screenshot 2022-09-22 at 22.14.15.png\relax }}{11}{figure.caption.11}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {1.3.1.3}Transcription pausing mechanism}{11}{subsubsection.1.3.1.3}\protected@file@percent }
\newlabel{transcription-pausing-mechanism}{{1.3.1.3}{11}{Transcription pausing mechanism}{subsubsection.1.3.1.3}{}}
\@writefile{toc}{\contentsline {section}{\numberline {1.4}4 - TCiC (1)}{12}{section.1.4}\protected@file@percent }
\newlabel{tcic-1}{{1.4}{12}{4 - TCiC (1)}{section.1.4}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {1.4.1}Structural basis of the nucleosome transition during RNA pol II passage - Kujirai et al 2018}{12}{subsection.1.4.1}\protected@file@percent }
\newlabel{structural-basis-of-the-nucleosome-transition-during-rna-pol-ii-passage---kujirai-et-al-2018}{{1.4.1}{12}{Structural basis of the nucleosome transition during RNA pol II passage - Kujirai et al 2018}{subsection.1.4.1}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {1.4.1.1}Nucleosome structure}{12}{subsubsection.1.4.1.1}\protected@file@percent }
\newlabel{nucleosome-structure}{{1.4.1.1}{12}{Nucleosome structure}{subsubsection.1.4.1.1}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {1.4.1.2}Cryo-EM}{12}{subsubsection.1.4.1.2}\protected@file@percent }
\newlabel{cryo-em}{{1.4.1.2}{12}{Cryo-EM}{subsubsection.1.4.1.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.11}{\ignorespaces Kujirai and Kurumizaka, \emph  {Curr Op. Struct. Biol.,} 2020\relax }}{13}{figure.caption.12}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {1.12}{\ignorespaces Screenshot 2022-10-05 at 22.57.06.png\relax }}{13}{figure.caption.13}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {1.13}{\ignorespaces Kujirai at al., \emph  {Science,} 2018\relax }}{13}{figure.caption.14}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {1.14}{\ignorespaces Screenshot 2022-10-05 at 23.02.04.png\relax }}{14}{figure.caption.15}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {1.15}{\ignorespaces Kujirai and Kurumizaka., \emph  {Curr Op. Struct. Biol.,} 2020 Template looping results in histone transfer from ahead of the transcribing RNApol II to behind\relax }}{14}{figure.caption.16}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {1.4.1.3}Summary of the main results}{14}{subsubsection.1.4.1.3}\protected@file@percent }
\newlabel{summary-of-the-main-results}{{1.4.1.3}{14}{Summary of the main results}{subsubsection.1.4.1.3}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {1.4.1.4}Template looping}{14}{subsubsection.1.4.1.4}\protected@file@percent }
\newlabel{template-looping}{{1.4.1.4}{14}{Template looping}{subsubsection.1.4.1.4}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.16}{\ignorespaces Lai and Pugh, \emph  {Nature Review Mol Cell Biol}. 2017\relax }}{15}{figure.caption.17}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {1.17}{\ignorespaces Van Oss \emph  {et al., TRENDS Biochem Sci.} 2017\relax }}{15}{figure.caption.18}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {1.4.1.5}Structural basis of nucleosome disassembly and reassembly by RNA P II elongation complex with FACT - Ehara et al.}{15}{subsubsection.1.4.1.5}\protected@file@percent }
\newlabel{structural-basis-of-nucleosome-disassembly-and-reassembly-by-rna-p-ii-elongation-complex-with-fact---ehara-et-al.}{{1.4.1.5}{15}{Structural basis of nucleosome disassembly and reassembly by RNA P II elongation complex with FACT - Ehara et al}{subsubsection.1.4.1.5}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.18}{\ignorespaces Screenshot 2022-10-10 at 10.35.12.png\relax }}{16}{figure.caption.19}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {1.19}{\ignorespaces Porrua \& Libri, Nature Review Mol Cell Biol, 2015\relax }}{16}{figure.caption.20}\protected@file@percent }
\@writefile{toc}{\contentsline {section}{\numberline {1.5}Termination}{16}{section.1.5}\protected@file@percent }
\newlabel{termination}{{1.5}{16}{Termination}{section.1.5}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {1.5.0.1}Promoter reporter assay}{16}{subsubsection.1.5.0.1}\protected@file@percent }
\newlabel{promoter-reporter-assay}{{1.5.0.1}{16}{Promoter reporter assay}{subsubsection.1.5.0.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.20}{\ignorespaces Anderson \& Sandelin, \emph  {Nature Review Gen}. 2019\relax }}{17}{figure.caption.21}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {1.5.0.2}\textbf  {Promoter types}}{17}{subsubsection.1.5.0.2}\protected@file@percent }
\newlabel{promoter-types}{{1.5.0.2}{17}{\texorpdfstring {\textbf {Promoter types}}{Promoter types}}{subsubsection.1.5.0.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.21}{\ignorespaces Lenhard \emph  {et al., Nature Rev Cancer} 2012\relax }}{18}{figure.caption.22}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {1.5.0.3}Transcription factor binding}{18}{subsubsection.1.5.0.3}\protected@file@percent }
\newlabel{transcription-factor-binding}{{1.5.0.3}{18}{Transcription factor binding}{subsubsection.1.5.0.3}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {1.22}{\ignorespaces Haberle \& Stark, \emph  {NatRevMolCelBiol.} 2018\relax }}{19}{figure.caption.23}\protected@file@percent }
\@writefile{toc}{\contentsline {chapter}{\numberline {2}Enhancer regulation}{20}{chapter.2}\protected@file@percent }
\@writefile{lof}{\addvspace {10\p@ }}
\@writefile{lot}{\addvspace {10\p@ }}
\@writefile{loa}{\addvspace {10\p@ }}
\@writefile{toc}{\contentsline {section}{\numberline {2.1}5 - TCiC (1)}{20}{section.2.1}\protected@file@percent }
\newlabel{tcic-1}{{2.1}{20}{5 - TCiC (1)}{section.2.1}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {2.1.0.1}Mediator complex}{20}{subsubsection.2.1.0.1}\protected@file@percent }
\newlabel{mediator-complex}{{2.1.0.1}{20}{Mediator complex}{subsubsection.2.1.0.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2.1}{\ignorespaces Screenshot 2022-10-07 at 10.47.50.png\relax }}{20}{figure.caption.24}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {2.2}{\ignorespaces Screenshot 2022-10-07 at 10.50.30.png\relax }}{21}{figure.caption.25}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {2.3}{\ignorespaces Soutourina\emph  {, Nature Review Mol Cell Biol.} 2018\relax }}{21}{figure.caption.26}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {2.4}{\ignorespaces Allen and Taatjes, \emph  {Nature Reviews Mol Cell Biol}. 2015\relax }}{22}{figure.caption.27}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {2.5}{\ignorespaces Bugter \emph  {et al., Nature Review Cancer}, 2021\relax }}{22}{figure.caption.28}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {2.1.1}Wnt signalling pathway}{22}{subsection.2.1.1}\protected@file@percent }
\newlabel{wnt-signalling-pathway}{{2.1.1}{22}{Wnt signalling pathway}{subsection.2.1.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2.6}{\ignorespaces Screenshot 2022-10-10 at 11.04.14.png\relax }}{23}{figure.caption.29}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {2.1.1.1}$\beta $ -catenin structure}{23}{subsubsection.2.1.1.1}\protected@file@percent }
\newlabel{ux3b2-catenin-structure}{{2.1.1.1}{23}{$\beta $ -catenin structure}{subsubsection.2.1.1.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2.7}{\ignorespaces Valenta \emph  {et al., EMBO J.} 2012\relax }}{24}{figure.caption.30}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {2.1.1.2}\textbf  {The canonical Wnt/$\beta $ -catenin pathway is crucially involved in colorectal cancer}}{24}{subsubsection.2.1.1.2}\protected@file@percent }
\newlabel{the-canonical-wntux3b2-catenin-pathway-is-crucially-involved-in-colorectal-cancer}{{2.1.1.2}{24}{\texorpdfstring {\textbf {The canonical Wnt/$\beta $ -catenin pathway is crucially involved in colorectal cancer}}{The canonical Wnt/$\beta $ -catenin pathway is crucially involved in colorectal cancer}}{subsubsection.2.1.1.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2.8}{\ignorespaces McDonald \emph  {et al., Dev Cell}, 2009\relax }}{25}{figure.caption.31}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {2.9}{\ignorespaces Firestein \emph  {et al., Nature} 2008\relax }}{25}{figure.caption.32}\protected@file@percent }
\@writefile{toc}{\contentsline {section}{\numberline {2.2}6- Transcriptional Control in Cancer}{26}{section.2.2}\protected@file@percent }
\newlabel{transcriptional-control-in-cancer}{{2.2}{26}{6- Transcriptional Control in Cancer}{section.2.2}{}}
\@writefile{toc}{\contentsline {section}{\numberline {2.3}CREP/p300}{26}{section.2.3}\protected@file@percent }
\newlabel{crepp300}{{2.3}{26}{CREP/p300}{section.2.3}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {2.3.0.1}CREP/p300 structure}{26}{subsubsection.2.3.0.1}\protected@file@percent }
\newlabel{crepp300-structure}{{2.3.0.1}{26}{CREP/p300 structure}{subsubsection.2.3.0.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2.10}{\ignorespaces Wang \emph  {et al., Cell Mol Life Sci.} 2013\relax }}{27}{figure.caption.33}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {2.11}{\ignorespaces Screenshot 2022-10-12 at 09.01.27.png\relax }}{27}{figure.caption.34}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {2.3.1}\textbf  {TSSa-RNAs transcription}}{28}{subsection.2.3.1}\protected@file@percent }
\newlabel{tssa-rnas-transcription}{{2.3.1}{28}{\texorpdfstring {\textbf {TSSa-RNAs transcription}}{TSSa-RNAs transcription}}{subsection.2.3.1}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {2.3.1.1}Properties of eRNAs}{29}{subsubsection.2.3.1.1}\protected@file@percent }
\newlabel{properties-of-ernas}{{2.3.1.1}{29}{Properties of eRNAs}{subsubsection.2.3.1.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2.12}{\ignorespaces Studniarek \emph  {et al., Trends in Genetics,} 2021\relax }}{30}{figure.caption.35}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {2.3.1.2}\textbf  {Assessing whether the CRC 8q24 risk region acts as an enhancer}}{30}{subsubsection.2.3.1.2}\protected@file@percent }
\newlabel{assessing-whether-the-crc-8q24-risk-region-acts-as-an-enhancer}{{2.3.1.2}{30}{\texorpdfstring {\textbf {Assessing whether the CRC 8q24 risk region acts as an enhancer}}{Assessing whether the CRC 8q24 risk region acts as an enhancer}}{subsubsection.2.3.1.2}{}}
\@writefile{toc}{\contentsline {chapter}{\numberline {3}CTCF}{32}{chapter.3}\protected@file@percent }
\@writefile{lof}{\addvspace {10\p@ }}
\@writefile{lot}{\addvspace {10\p@ }}
\@writefile{loa}{\addvspace {10\p@ }}
\@writefile{toc}{\contentsline {section}{\numberline {3.1}7- Transcriptional Control in Cancer}{32}{section.3.1}\protected@file@percent }
\newlabel{transcriptional-control-in-cancer}{{3.1}{32}{7- Transcriptional Control in Cancer}{section.3.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.1}{\ignorespaces Screenshot 2022-10-14 at 10.52.51.png\relax }}{32}{figure.caption.36}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.2}{\ignorespaces Screenshot 2022-10-14 at 10.54.02.png\relax }}{33}{figure.caption.37}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.3}{\ignorespaces Screenshot 2022-10-14 at 11.20.37.png\relax }}{35}{figure.caption.38}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.4}{\ignorespaces Screenshot 2022-10-14 at 19.51.43.png\relax }}{36}{figure.caption.39}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {3.1.0.1}Cohesin mediates transcriptional insulation by CCCTC-binding factor}{36}{subsubsection.3.1.0.1}\protected@file@percent }
\newlabel{cohesin-mediates-transcriptional-insulation-by-ccctc-binding-factor}{{3.1.0.1}{36}{Cohesin mediates transcriptional insulation by CCCTC-binding factor}{subsubsection.3.1.0.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.5}{\ignorespaces Screenshot 2022-10-14 at 19.50.44.png\relax }}{37}{figure.caption.40}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.6}{\ignorespaces Herold \emph  {et al., Development,} 2012\relax }}{37}{figure.caption.41}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.7}{\ignorespaces Screenshot 2022-10-14 at 12.10.46.png\relax }}{37}{figure.caption.42}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.8}{\ignorespaces Screenshot 2022-10-14 at 19.52.56.png\relax }}{38}{figure.caption.43}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.9}{\ignorespaces Screenshot 2022-10-19 at 08.48.41.png\relax }}{39}{figure.caption.44}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {3.1.0.2}Chromosome Conformation Capture (3C)}{39}{subsubsection.3.1.0.2}\protected@file@percent }
\newlabel{chromosome-conformation-capture-3c}{{3.1.0.2}{39}{Chromosome Conformation Capture (3C)}{subsubsection.3.1.0.2}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {3.1.0.3}Hi-C approach}{39}{subsubsection.3.1.0.3}\protected@file@percent }
\newlabel{hi-c-approach}{{3.1.0.3}{39}{Hi-C approach}{subsubsection.3.1.0.3}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.10}{\ignorespaces Lieberma-Aiden \emph  {et al., Science} 2009\relax }}{40}{figure.caption.45}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.11}{\ignorespaces Lieberma-Aiden \emph  {et al., Science} 2009\relax }}{40}{figure.caption.46}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.12}{\ignorespaces Screenshot 2022-10-19 at 09.10.50.png\relax }}{41}{figure.caption.47}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {3.1.0.4}Optimization of Hi-C approach}{41}{subsubsection.3.1.0.4}\protected@file@percent }
\newlabel{optimization-of-hi-c-approach}{{3.1.0.4}{41}{Optimization of Hi-C approach}{subsubsection.3.1.0.4}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.13}{\ignorespaces Screenshot 2022-10-19 at 09.11.30.png\relax }}{42}{figure.caption.48}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.14}{\ignorespaces Rowley and Corces, \emph  {Nature Rev Genetics} 2018\relax }}{43}{figure.caption.49}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3.15}{\ignorespaces Dixon \emph  {et al., Mol Cell.} 2016\relax }}{43}{figure.caption.50}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {3.1.0.5}Promoter-Enhancer Communication Occurs Primarily within Insulated neighbourhoods}{44}{subsubsection.3.1.0.5}\protected@file@percent }
\newlabel{promoter-enhancer-communication-occurs-primarily-within-insulated-neighbourhoods}{{3.1.0.5}{44}{Promoter-Enhancer Communication Occurs Primarily within Insulated neighbourhoods}{subsubsection.3.1.0.5}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3.16}{\ignorespaces Sun et al., 2019\relax }}{45}{figure.caption.51}\protected@file@percent }
\@writefile{toc}{\contentsline {chapter}{\numberline {4}TCIC}{46}{chapter.4}\protected@file@percent }
\@writefile{lof}{\addvspace {10\p@ }}
\@writefile{lot}{\addvspace {10\p@ }}
\@writefile{loa}{\addvspace {10\p@ }}
\@writefile{toc}{\contentsline {section}{\numberline {4.1}13- Transcriptional Control in Cancer}{46}{section.4.1}\protected@file@percent }
\newlabel{transcriptional-control-in-cancer}{{4.1}{46}{13- Transcriptional Control in Cancer}{section.4.1}{}}
\@writefile{toc}{\contentsline {section}{\numberline {4.2}Targeting transcription in cancer}{46}{section.4.2}\protected@file@percent }
\newlabel{targeting-transcription-in-cancer}{{4.2}{46}{Targeting transcription in cancer}{section.4.2}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.2.0.1}Age-related remodellling of \textbf  {oesophageal epithelia by mutated cancer drivers}}{46}{subsubsection.4.2.0.1}\protected@file@percent }
\newlabel{age-related-remodellling-of-oesophageal-epithelia-by-mutated-cancer-drivers}{{4.2.0.1}{46}{\texorpdfstring {Age-related remodellling of \textbf {oesophageal epithelia by mutated cancer drivers}}{Age-related remodellling of oesophageal epithelia by mutated cancer drivers}}{subsubsection.4.2.0.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.1}{\ignorespaces Yokoyama et al., Nature 2019\relax }}{46}{figure.caption.52}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {4.2}{\ignorespaces Yokoyama et al., Nature 2019\relax }}{47}{figure.caption.53}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {4.3}{\ignorespaces Yokoyama et al., Nature 2019\relax }}{48}{figure.caption.54}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {4.4}{\ignorespaces Screen Shot 2022-11-04 at 11.25.54.png\relax }}{49}{figure.caption.55}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.2.0.2}Key points}{49}{subsubsection.4.2.0.2}\protected@file@percent }
\newlabel{key-points}{{4.2.0.2}{49}{Key points}{subsubsection.4.2.0.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.5}{\ignorespaces Gonda and Ramsay, \emph  {Nature Review Mol Cell Biology}, 2015\relax }}{50}{figure.caption.56}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {4.6}{\ignorespaces Bywater \emph  {et al., Nature Review Cancer-} 2013\relax }}{51}{figure.caption.57}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {4.2.1}Target transcription in cancer}{51}{subsection.4.2.1}\protected@file@percent }
\newlabel{target-transcription-in-cancer}{{4.2.1}{51}{Target transcription in cancer}{subsection.4.2.1}{}}
\@writefile{toc}{\contentsline {section}{\numberline {4.3}15- Transcriptional Control in Cancer}{52}{section.4.3}\protected@file@percent }
\newlabel{transcriptional-control-in-cancer}{{4.3}{52}{15- Transcriptional Control in Cancer}{section.4.3}{}}
\@writefile{toc}{\contentsline {section}{\numberline {4.4}BRD4}{52}{section.4.4}\protected@file@percent }
\newlabel{brd4}{{4.4}{52}{BRD4}{section.4.4}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.4.0.1}Selective inhibition of Tumor Oncogenes by Disruption of Super-Enhancers}{52}{subsubsection.4.4.0.1}\protected@file@percent }
\newlabel{selective-inhibition-of-tumor-oncogenes-by-disruption-of-super-enhancers}{{4.4.0.1}{52}{Selective inhibition of Tumor Oncogenes by Disruption of Super-Enhancers}{subsubsection.4.4.0.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.7}{\ignorespaces Screen Shot 2022-11-13 at 19-35-28.png\relax }}{53}{figure.caption.58}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {4.8}{\ignorespaces Screen Shot 2022-11-13 at 19-40-17.png\relax }}{53}{figure.caption.59}\protected@file@percent }
\@writefile{toc}{\contentsline {section}{\numberline {4.5}YAP/TAZ}{53}{section.4.5}\protected@file@percent }
\newlabel{yaptaz}{{4.5}{53}{YAP/TAZ}{section.4.5}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.9}{\ignorespaces Screen Shot 2022-11-13 at 19-41-35.png\relax }}{54}{figure.caption.60}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {4.10}{\ignorespaces Dupont et al., Nature 2011\relax }}{54}{figure.caption.61}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {4.11}{\ignorespaces Screen Shot 2022-11-13 at 19-48-01.png\relax }}{55}{figure.caption.62}\protected@file@percent }
\@writefile{toc}{\contentsline {section}{\numberline {4.6}TEAD}{55}{section.4.6}\protected@file@percent }
\newlabel{tead}{{4.6}{55}{TEAD}{section.4.6}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {4.6.1}YAP/TAZ/TEAD}{55}{subsection.4.6.1}\protected@file@percent }
\newlabel{yaptaztead}{{4.6.1}{55}{YAP/TAZ/TEAD}{subsection.4.6.1}{}}
\@writefile{toc}{\contentsline {section}{\numberline {4.7}17- Transcriptional Control in Cancer}{56}{section.4.7}\protected@file@percent }
\newlabel{transcriptional-control-in-cancer}{{4.7}{56}{17- Transcriptional Control in Cancer}{section.4.7}{}}
\@writefile{toc}{\contentsline {section}{\numberline {4.8}Nuclear receptors}{56}{section.4.8}\protected@file@percent }
\newlabel{nuclear-receptors}{{4.8}{56}{Nuclear receptors}{section.4.8}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.12}{\ignorespaces Screen Shot 2022-11-18 at 11-11-12.png\relax }}{57}{figure.caption.63}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {4.8.1}Estrogen receptor \(\alpha \)}{57}{subsection.4.8.1}\protected@file@percent }
\newlabel{estrogen-receptor-alpha}{{4.8.1}{57}{\texorpdfstring {Estrogen receptor \(\alpha \)}{Estrogen receptor \textbackslash alpha}}{subsection.4.8.1}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {4.8.2}ER$\alpha $) in breast cancer}{57}{subsection.4.8.2}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {4.13}{\ignorespaces Screen Shot 2022-11-18 at 11-06-54.png\relax }}{58}{figure.caption.64}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {4.14}{\ignorespaces Screen Shot 2022-11-18 at 11-14-09.png\relax }}{58}{figure.caption.65}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.8.2.1}Mechanisms provoking breast cancer drug resistance}{59}{subsubsection.4.8.2.1}\protected@file@percent }
\newlabel{mechanisms-provoking-breast-cancer-drug-resistance}{{4.8.2.1}{59}{Mechanisms provoking breast cancer drug resistance}{subsubsection.4.8.2.1}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.8.2.2}Summary}{59}{subsubsection.4.8.2.2}\protected@file@percent }
\newlabel{summary}{{4.8.2.2}{59}{Summary}{subsubsection.4.8.2.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {4.15}{\ignorespaces Screen Shot 2022-11-18 at 11-59-02.png\relax }}{60}{figure.caption.66}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.8.2.3}ER$\alpha $ transcriptional program}{60}{subsubsection.4.8.2.3}\protected@file@percent }
\newlabel{ertranscriptional-program}{{4.8.2.3}{60}{\texorpdfstring {ER$\alpha $ transcriptional program}{ERtranscriptional program}}{subsubsection.4.8.2.3}{}}
\@writefile{toc}{\contentsline {chapter}{\numberline {5}Genome instability}{62}{chapter.5}\protected@file@percent }
\@writefile{lof}{\addvspace {10\p@ }}
\@writefile{lot}{\addvspace {10\p@ }}
\@writefile{loa}{\addvspace {10\p@ }}
\@writefile{toc}{\contentsline {section}{\numberline {5.1}19- Transcriptional Control in Cancer}{62}{section.5.1}\protected@file@percent }
\newlabel{transcriptional-control-in-cancer}{{5.1}{62}{19- Transcriptional Control in Cancer}{section.5.1}{}}
\@writefile{toc}{\contentsline {section}{\numberline {5.2}Transcription and genome instability}{62}{section.5.2}\protected@file@percent }
\newlabel{transcription-and-genome-instability}{{5.2}{62}{Transcription and genome instability}{section.5.2}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {5.2.1}R-loops}{62}{subsection.5.2.1}\protected@file@percent }
\newlabel{r-loops}{{5.2.1}{62}{R-loops}{subsection.5.2.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {5.1}{\ignorespaces Hamperl and Cimprich, DNA Repair, 2014\relax }}{62}{figure.caption.67}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {5.2.1.1}R-loop degradation}{63}{subsubsection.5.2.1.1}\protected@file@percent }
\newlabel{r-loop-degradation}{{5.2.1.1}{63}{R-loop degradation}{subsubsection.5.2.1.1}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {5.2.1.2}R-loop recognition and distribution}{63}{subsubsection.5.2.1.2}\protected@file@percent }
\newlabel{r-loop-recognition-and-distribution}{{5.2.1.2}{63}{R-loop recognition and distribution}{subsubsection.5.2.1.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {5.2}{\ignorespaces Screen Shot 2022-11-23 at 10-18-00.png\relax }}{64}{figure.caption.68}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {5.2.1.3}VIM-antisense1}{64}{subsubsection.5.2.1.3}\protected@file@percent }
\newlabel{vim-antisense1}{{5.2.1.3}{64}{VIM-antisense1}{subsubsection.5.2.1.3}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {5.3}{\ignorespaces Screen Shot 2022-11-25 at 11-49-03.png\relax }}{65}{figure.caption.69}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {5.2.1.4}Main findings}{65}{subsubsection.5.2.1.4}\protected@file@percent }
\newlabel{main-findings}{{5.2.1.4}{65}{Main findings}{subsubsection.5.2.1.4}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {5.2.2}HOTTIP-dependent R-loop formation regulates CTCF boundary activity and TAD integrity in leukemia}{65}{subsection.5.2.2}\protected@file@percent }
\newlabel{hottip-dependent-r-loop-formation-regulates-ctcf-boundary-activity-and-tad-integrity-in-leukemia}{{5.2.2}{65}{HOTTIP-dependent R-loop formation regulates CTCF boundary activity and TAD integrity in leukemia}{subsection.5.2.2}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {5.2.2.1}Conclusions}{67}{subsubsection.5.2.2.1}\protected@file@percent }
\newlabel{conclusions}{{5.2.2.1}{67}{Conclusions}{subsubsection.5.2.2.1}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {5.2.3}HOTTIP lncRNA Promotes Hematopoietic Stem Cells Self-Renewal Leading to AML-like Disease in Mice}{67}{subsection.5.2.3}\protected@file@percent }
\newlabel{hottip-lncrna-promotes-hematopoietic-stem-cells-self-renewal-leading-to-aml-like-disease-in-mice}{{5.2.3}{67}{HOTTIP lncRNA Promotes Hematopoietic Stem Cells Self-Renewal Leading to AML-like Disease in Mice}{subsection.5.2.3}{}}
\@writefile{toc}{\contentsline {section}{\numberline {5.3}20- Transcriptional Control in Cancer}{67}{section.5.3}\protected@file@percent }
\newlabel{transcriptional-control-in-cancer}{{5.3}{67}{20- Transcriptional Control in Cancer}{section.5.3}{}}
\@writefile{toc}{\contentsline {section}{\numberline {5.4}Transcription and genome instability II}{67}{section.5.4}\protected@file@percent }
\newlabel{transcription-and-genome-instability-ii}{{5.4}{67}{Transcription and genome instability II}{section.5.4}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {5.4.1}DNA damage}{67}{subsection.5.4.1}\protected@file@percent }
\newlabel{dna-damage}{{5.4.1}{67}{DNA damage}{subsection.5.4.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {5.4}{\ignorespaces Base excision repair\relax }}{68}{figure.caption.70}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {5.4.1.1}R loop modified bases}{68}{subsubsection.5.4.1.1}\protected@file@percent }
\newlabel{r-loop-modified-bases}{{5.4.1.1}{68}{R loop modified bases}{subsubsection.5.4.1.1}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {5.4.2}Apical kinases}{68}{subsection.5.4.2}\protected@file@percent }
\newlabel{apical-kinases}{{5.4.2}{68}{Apical kinases}{subsection.5.4.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {5.5}{\ignorespaces R loop repair\relax }}{69}{figure.caption.71}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {5.6}{\ignorespaces Apical kinases\relax }}{69}{figure.caption.72}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {5.7}{\ignorespaces Blackford and Jackson, \emph  {Mol Cell}, 2017\relax }}{70}{figure.caption.73}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {5.8}{\ignorespaces Trenner and Satori, Frontiers in Oncology 2019\relax }}{70}{figure.caption.74}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {5.4.3}Topoisomerases}{71}{subsection.5.4.3}\protected@file@percent }
\newlabel{topoisomerases}{{5.4.3}{71}{Topoisomerases}{subsection.5.4.3}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {5.4.3.1}A topoisomerase IIb-mediated dsDNA break required for Regulated Transcription}{71}{subsubsection.5.4.3.1}\protected@file@percent }
\newlabel{a-topoisomerase-iib-mediated-dsdna-break-required-for-regulated-transcription}{{5.4.3.1}{71}{A topoisomerase IIb-mediated dsDNA break required for Regulated Transcription}{subsubsection.5.4.3.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {5.9}{\ignorespaces Screen Shot 2022-11-30 at 10-03-17.png\relax }}{72}{figure.caption.75}\protected@file@percent }
\@writefile{toc}{\contentsline {subsubsection}{\numberline {5.4.3.2}BRCA1}{72}{subsubsection.5.4.3.2}\protected@file@percent }
\newlabel{brca1}{{5.4.3.2}{72}{BRCA1}{subsubsection.5.4.3.2}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {5.4.3.3}Stark et al.}{72}{subsubsection.5.4.3.3}\protected@file@percent }
\newlabel{stark-et-al.}{{5.4.3.3}{72}{Stark et al}{subsubsection.5.4.3.3}{}}
